Stock MEDCL MEDINCELL S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights MedinCell S.A.

Equities

MEDCL

FR0004065605

Pharmaceuticals

Market Closed - Euronext Paris
Other stock markets
 11:35:11 2025-01-24 am EST 		5-day change 1st Jan Change
15.98 EUR +0.63% Intraday chart for MedinCell S.A. -1.96% -3.85%
Dec. 13 Eutelsat: delisted from the SBF 120 and CAC Mid 60 indices CF
Dec. 13 Euroapi: delisted from the SBF 120 and CAC Mid 60 indices CF

Highlights

Search
See the results
MedinCell S.A. Provides Earning Guidance for the Year Ending March 31, 2025
Dec. 10
 CI
MedinCell S.A. Reports Earnings Results for the Half Year Ended September 30, 2024
Dec. 09
 CI
Medincell: positive results in arthroplasty
Dec. 09
 CF
Medincell: in the green with study data
Nov. 04
 CF
Medincell: program with AbbVie enters pre-clinical phase
24-09-04
 CF
Medincell Announces Progress in the Development of Its Products Portfolio and R&D Pipeline
24-09-03
 CI
Medincell: R&D advances soon to be presented at congress
24-07-02
 CF
Medincell: a 'new era' after a 'pivotal' 2023
24-06-10
 CF
MedinCell S.A. Reports Earnings Results for the Full Year Ended March 31, 2024
24-06-10
 CI
Medincell: share price falls after disappointing clinical study
24-05-15
 CF
Medincell Provides Update on Phase 3 mdc-CWM Clinical Trial
24-05-14
 CI
Medincell: share price rises on resumption of trading
24-05-09
 CF
CAC40: remains in green in a neglected market
24-05-08
 CF
Medincell: positive results in schizophrenia
24-05-08
 CF
Medincell Listing Temporarily Suspended on Euronext Paris
24-05-08
 MT
Teva and Medincell's schizophrenia drug meets main goal of late-stage study
24-05-08
 RE
Teva Pharmaceuticals and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-?749 as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
24-05-08
 CI
Medincell: share price rises following agreement with AbbVie
24-04-17
 CF
Medincell, AbbVie to Co-Develop Injectable Therapeutics
24-04-16
 DJ
Medincell Enters Into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies
24-04-16
 CI
Medincell: Unitaid grant to combat malaria
24-04-09
 CF
Medincell Receives $6 Million Extension Grant from Unitaid for Malaria Drug Trial
24-04-09
 MT
Medincell S.A. Reaches Commercial Stage with the Market Launch by Teva of Uzedy? for the Treatment of Schizophrenia
24-03-15
 CI
Teva Pharmaceutical Industries Ltd. Announces Recruitment Completion of Phase 3 Clinical Study of mdc-TJK / Olanzapine Long-Acting Injectable
24-01-09
 CI
MedinCell: first-half net loss reduced
23-12-20
 CF
Become a member to access more news.
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MEDCL Stock
  4. News MedinCell S.A.
  5. Highlights